Kumar S. Nemmani
Bhimavaram, AP 534202, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer's in Rats: Insights into the Underlying Mechanisms.
Journal: ACS chemical neuroscience
Published: September 05, 2023
Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF.
Journal: CNS & neurological disorders drug targets
Published: April 17, 2023
Advancing health care via artificial intelligence: From concept to clinic.
Journal: European journal of pharmacology
Published: June 15, 2022
Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis.
Journal: European journal of pharmacology
Published: January 04, 2022
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-N-(2'-methyl-3'-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1'-biphenyl]-4-yl)benzamide. Structure-Activity Relationship and Preclinical Characterization.
Journal: Journal of medicinal chemistry
Published: November 29, 2021
Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides.
Journal: Journal of medicinal chemistry
Published: May 06, 2020
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization.
Journal: Bioorganic & medicinal chemistry
Published: April 25, 2020
Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Journal: Expert opinion on therapeutic targets
Published: June 19, 2018
Prediction of volume of distribution in preclinical species and humans: application of simplified physiologically based algorithms.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: May 18, 2018
Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes.
Journal: Medical molecular morphology
Published: April 16, 2018
Prediction of Tumor-to-Plasma Ratios of Basic Compounds in Subcutaneous Xenograft Mouse Models.
Journal: European journal of drug metabolism and pharmacokinetics
Published: December 19, 2017
Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet.
Journal: Biochemical and biophysical research communications
Published: November 28, 2017
Last Updated: 09/26/2026